EMN

In Q1 2026, Eastman reported strong sequential sales volume/mix improvement in specialty businesses, leading to a stock surge. The Middle East conflict tightened market conditions for certain olefin products, impacting margins positively in the Chemical Intermediates segment but introducing operational risks for the Fibers segment. Eastman implemented price increases to counteract inflation. The Fibers segment experienced lower sales volume due to customer inventory destocking. The company made progress in the commercial ramp-up of its Kingsport methanolysis facility. EMN shares increased by 15.1% from the beginning of 2026 to May 9, 2026, and analysts have given Eastman Chemical a consensus rating of "Moderate Buy" or "Buy."